35 results
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS
 • Pneumocystis pneumonia (PCP)
IDSA - Prophylaxis ... (HAV) infection ... (HBV) infection ... #OIs #HIVAIDS #IDSA ... #management #pharmacology
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS
 • Pneumocystis pneumonia (PCP)
IDSA - Prophylaxis ... (HAV) infection ... (HBV) infection ... #OIs #HIVAIDS #IDSA ... #management #pharmacology
Asthma Medications and Mechanism of Action

#Asthma #Medications #Drugs #Pulmonary #Pharmacology #Management #Treatment
Asthma Medications ... Mechanism of Action #Asthma ... Medications #Drugs #Pulmonary ... #Pharmacology # ... Management #Treatment
IDSA Aspergillosis Treatment
 • Invasive pulmonary aspergillosis (IPA)
 • CNS aspergillosis
 • Cardiac Aspergillus infection
 •
IDSA Aspergillosis ... Treatment • Invasive pulmonary ... Aspergillosis #Treatment #management ... #pharmacology # ... IDSA
IDSA Recommendations for Preventing Human Papillomavirus Infections and Cervical Cancer Screening for Women with in HIV-AIDS
Recommendations
IDSA Recommendations ... known to have HIV ... HumanPapillomavirus #IDSA ... Prevention #Treatment #management ... infections #HIVAIDS #pharmacology
Here is a quick guide on the common direct-acting antivirals (DAAs) for chronic hepatitis C virus
chronic hepatitis C virus ... (HCV) infection ... table #treatment #hcv ... HepC #HepatitisC #Management ... #Pharmacology
Asthma Maintenance Therapy - Stepwise Approach 

Low dose ICS 
-> Low dose ICS/LABA or Med/High dose
Asthma Maintenance ... nonpharmacologic management ... Stepwise #Therapy #Management ... #Pharmacology # ... Pulmonary
Bronchiectasis: diagnosis and management 

Causes of localized -> diffuse bronchiectasis
Foreign body, Bronchial stenosis (tumor, .. ),
diagnosis and management ... Bacterial pneumonia, Virus ... deficiency, CVID+++, HIV ... Bronchiectasis #diagnosis #management ... workup #algorithm #pulmonary
Biologic therapy for eosinophilic asthma 
• Mepolizumab (Nucala) 
  • Anti-lL-5, 100 mg SQ q4
for eosinophilic asthma ... #eosinophilic #asthma ... #Medications #pharmacology ... #pulmonary #management
IDSA Recommendations for Treating Herpes Simplex Virus (HSV) Infections in HIV-AIDS
Treating Orolabial Lesions (Duration: 5–10 days)
IDSA Recommendations ... Herpes Simplex Virus ... #IDSA #Prevention ... #Treatment #management ... infections #HIVAIDS #pharmacology